• We searched for the
    best oncologist and found
    the one for my wife and me
    with Dr. Gorman.
    He is excellent.

    ~ Patient

  • Kimberly S Hess, ANP-BC
    John M Cho, MD
    Rick F Gorman Jr., MD
    W. Chris Taylor, MD

  • Don't waste a moment...
                  let the healing begin.

  • We have been treated so
    special by Dr. Taylor and his staff.
    We couldn't have asked for
    more. We are extremely grateful
    we found such a
    caring doctor to help us.

    ~ Patient

  •  

     

    Expert treatment
    delivered with
    care and comfort.

 

General Clinical Trial Information

What are clinical trials? Clinical trials are studies that research new cancer treatment therapies with the goal of improving current standard-of-care treatments. Clinical trials allow our patients to take advantage of therapies which are not yet available outside of the research community. We appreciate the contributions our clinical trials patients make to research, because the findings can benefit other cancer patients in the future.

Please visit the cancer.gov website for more information about clinical trials.

Available Clinical Trials

DIFFUSE LARGE B-CELL LYMPHOMA

Principal Investigator: Richard Gorman, MD

Protocol Name: An open-label, randomized, phase 2 study to assess the effectiveness of RCHOP with or without Velcade in previously untreated patients with non-germinal center B-cell-like diffuse large B-cell lymphoma.

LUNG CANCER

Principal Investigator: Chris Taylor, MD

Protocol Name: A multicenter phase 2 trial of Carboplatin, Pemetrexed and Bevacizumab followed by Pemetrexed and Bevacizumab maintenance therapy in patients with a light or never smoking history.

METASTATIC COLORECTAL CANCER

Principal Investigator: Chris Taylor, MD

Protocol Name: A Multi-Center, Randomized, Placebo-Controlled Phase 2 Study of Regorafenib in Combination with FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) versus Placebo with FOLFIRI as Second-Line Therapy in Patients with K-RAS or BRAF Mutant Metastatic Colorectal Cancer.

PROSTATE CANCER

Principal Investigator: John Cho, MD

Protocol Name: A registry of Sipuleucel-T therapy in men with advanced prostate cancer.

CHRONIC LYMPHOCYTIC LEUKEMIA

Principal Investigator: Richard Gorman, MD

Protocol Name: A phase 2 open-label study of MEDI-551 and Bendamustine versus Rituximab and Bendamustine in adults with relapsed or refractory CLL.

MULTIPLE MYELOMA

Principal Investigator: John Cho, MD

Protocol Name: “CoMMpass” A prospective, longitudinal, observational stuy in newly diagnosed multiple myeloma (MM) patients to assess the relationship between patient outcomes, treatment regimens and molecular profiles.

MULTIPLE CANCER SITES

Principal Investigator: John Cho, MD

Protocol Name: Study to Investigate the Relationship Between Physician-Assessed Febrile Neutropenia (FN) Risk Probability Score and Prediction Tool FN Risk Probability Score for Patients with Non-myeloid Malignancies.